Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials

BACKGROUND: Emerging data suggest that outcomes for advanced hepatocellular carcinoma (HCC) treated with sorafenib may have improved over time. We aimed to provide robust, time-to-event estimates of survival outcomes for sorafenib in advanced HCC. SUMMARY: In this systematic review and individual pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Darren Jun Hao, Tang, Ansel Shao Pin, Lim, Wen Hui, Ng, Cheng Han, Nah, Benjamin, Fu, Clarissa, Xiao, Jieling, Koh, Benjamin, Tay, Phoebe Wen Lin, Tan, Eunice X., Teng, Margaret, Syn, Nicholas, Muthiah, Mark D., Tamaki, Nobuharu, Lee, Sung Won, Kim, Beom Kyung, Yau, Thomas, Vogel, Arndt, Loomba, Rohit, Huang, Daniel Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601853/
https://www.ncbi.nlm.nih.gov/pubmed/37901764
http://dx.doi.org/10.1159/000529824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601853/
https://www.ncbi.nlm.nih.gov/pubmed/37901764
http://dx.doi.org/10.1159/000529824

Ejemplares similares